MEDICAL AFFAIRS
Abbott Diabetes Care
Congress Materials
Advanced Technologies & Treatments for Diabetes
2025 Congress
19 March – 22 March, 2025 | Amsterdam
Presentations and Materials
Poster
Self-reported severe hypoglycemia after switching from real-time CGM with predictive alarms to intermittently scanned CGM in people with Type 1 diabetes in Sweden.
ATTD 2025 Abstracts, Diabetes Technology & Therapeutics, 2025;27(2_suppl).
Fleur Levrat-Guillen, Katarina Eeg-Olofsson, David Nathanson, Tim Spelman, Mattias Kyhlstedt, Chris Chesters, Jan Bolinder.
Presentation
FRONTIER – FreeStyle Libre use in Ontario among patients with T2D – Evidence from real-world practice: Patients aged >65 year on non-insulin therapies.
ATTD 2025 Abstracts, Diabetes Technology & Therapeutics, 2025;27(2_suppl).
Alexandria Ratzki-Leewing, Stewart Harris, Remi Rabasa-Lhoret, Yeesha Poon.
Poster
Association of FreeStyle Libre continuous glucose monitoring utilization and GLP-1 receptor agonist discontinuation: A real-world study.
ATTD 2025 Abstracts, Diabetes Technology & Therapeutics, 2025;27(2_suppl).
Eileen Huang, Anila Bindal.
Poster
Impact of FreeStyle Libre 3 on glycemic control and engagement with diabetes self-management as measured by the IGMSS: A randomized controlled trial.
ATTD 2025 Abstracts, Diabetes Technology & Therapeutics, 2025;27(2_suppl).
Emily Soriano, William Polonsky, Michael Vallis, Andrew Kwist, Fleur Levrat-Guillen.
